CVE-2023-40153

The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.
References
Link Resource
https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02 Third Party Advisory US Government Resource
Configurations

Configuration 1 (hide)

cpe:2.3:a:dexma:dexgate:20130114:*:*:*:*:*:*:*

History

25 Oct 2023, 13:39

Type Values Removed Values Added
References (MISC) https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02 - (MISC) https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02 - Third Party Advisory, US Government Resource
CVSS v2 : unknown
v3 : unknown
v2 : unknown
v3 : 6.1
CWE CWE-79
CPE cpe:2.3:a:dexma:dexgate:20130114:*:*:*:*:*:*:*
First Time Dexma
Dexma dexgate

19 Oct 2023, 19:36

Type Values Removed Values Added
New CVE

Information

Published : 2023-10-19 19:15

Updated : 2024-02-28 20:33


NVD link : CVE-2023-40153

Mitre link : CVE-2023-40153

CVE.ORG link : CVE-2023-40153


JSON object : View

Products Affected

dexma

  • dexgate
CWE
CWE-79

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')